SCHEMBL4852385

SCHEMBL4852385

COc1ccc(-c2ccc(OCCN(C)C)c(C(=O)/C=C/c3ccccc3CN(C)C)c2)c(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
ATM Q13315 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ABCG2 Q9UNQ0 2/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
TNFRSF1A P19438 2/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MCHR1 Q99705 1/20 0.40
PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853913 1.00 MAPT (0.44) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4857401 0.94 MAPT (0.45) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4846136 0.94 MAPT (0.45) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4850209 0.91 HTR7 (0.46) SMN1; SMN2ALDH1A1MCHR1
SCHEMBL4852586 0.91 HTR7 (0.46) SMN1; SMN2ALDH1A1MCHR1
SCHEMBL4852387 0.91 PDE4A (0.46) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4852887 0.86 ALDH1A1 (0.42) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4846148 0.86 ALDH1A1 (0.42) MAPTSMN1; SMN2LMNAGAAATM
SCHEMBL4851088 0.86 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1
SCHEMBL4852630 0.86 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed